News Releases

18 Jun '20
CAMBRIDGE, Mass. & MONTRÉAL --(BUSINESS WIRE)--Jun. 18, 2020-- Repare Therapeutics Inc. (Nasdaq: RPTX), a leading precision oncology company enabled by our proprietary synthetic lethality approach to the discovery and development of novel therapeutics, today announced the pricing of its upsized